ArticleGene therapy2025

AAV-based gene replacement therapy prevents and halts manifestation of abnormal neurological phenotypes in a novel mouse model of PMM2-CDG.

Mian-Ling Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.